Narrativa® Life Sciences Collateral Generator
Transform scientific documentation into scalable, AI-driven marketing collateral
The Life Sciences Collateral Generator, available within the Narrativa Navigator platform, enables pharmaceutical teams to transform whitepapers, clinical documents, and market insights into high-impact, AI-driven marketing collateral—accelerating commercialization while maintaining consistency, accuracy, and compliance.






AI-Driven Collateral Generation for Pharma Commercialization
Pharmaceutical commercialization teams must continuously translate complex clinical and market data into a wide range of materials—from detail aids and email campaigns to landing pages and social content. This process is often manual, fragmented, and difficult to scale across channels and markets.
The Life Sciences Collateral Generator transforms this process by enabling teams to generate marketing and sales assets directly from validated source content such as clinical whitepapers, value dossiers, and case studies.
Built on Narrativa’s agentic AI framework, the platform connects clinical, scientific, and market data through a knowledge graph, ensuring that all generated collateral remains consistent, traceable, and aligned with core messaging.
- Generates AI-driven marketing collateral from existing scientific and commercial content
- Transforms whitepapers, value dossiers, and case studies into multichannel assets
- Supports outputs including detail aids (DAs), emailers, brochures, landing pages, and social content
- Maintains alignment with validated data, messaging frameworks, and brand guidelines
- Ensures traceability between generated assets and source insights
- Enables scalable content production across global commercialization teams
Key Benefits of AI-Driven Collateral Generation
Learn more: AI-Driven Marketing Collateral for Life Sciences
Pharma commercialization requires transforming clinical and market data into scalable, AI-driven marketing collateral. The Life Sciences Collateral Generator enables automated content activation across channels, audiences, and formats.
The platform ingests and structures key inputs—including clinical trial data, scientific evidence, real-world evidence (RWE), real-world data (RWD), patient-reported outcomes (PROs), and market insights such as payer data and value dossiers—to ensure all generated content is grounded in validated sources.
Using knowledge graph technology, it connects clinical, scientific, and commercial insights into a unified framework, maintaining consistent messaging across assets while ensuring full traceability between data and generated content.
AI agents then automate content generation workflows, transforming source materials into AI-driven marketing collateral such as email campaigns, landing page copy, and sales enablement assets, while supporting omnichannel commercialization strategies.
The result is a set of scalable, compliant, and ready-for-review deliverables, including market education materials, campaign collateral, and SEO-, AEO-, and AI-optimized content designed for modern discovery and engagement.
